The six patients showed varying degrees of clinical change after the start of treatment. In case I the patient had a severe JHR; the rash increased in intensity and the temperature rose to 38 8°C and the pulse rate to 100/minute; a slight fall in pulse rate produced a subsequent rise in blood pressure. This patient developed rigors, and observations and collection of blood samples were stopped at the six-hour interval. In case 2 the patient had a similar reaction with an increase in the intensity of the rash, a rise in temperature to 38 8°C, an increase in pulse rate to I 10/minute, and a similar but more pronounced change in blood pressure than in case 1. Both these patients reported severe symptoms including myalgia, arthralgia, anorexia, and nausea. In cases 3 and 4 the patients had less severe reactions with rises in temperature to 38-9°C and 38°C respectively and an increase in pulse rate to 100/minute. Both patients showed a slight rash potentiation and felt nauseated and unwell for short periods. In cases 5 and 6 and the control subject 7 no reactions either objective or subjective occurred. When they did occur reactions began three to four hours after initiation of treatment.
A fall in intravascular kininogen occurred in several patients. This fall was most pronounced in the patients in cases 1 and 2 who had severe JHRs (figure). In case 1 the patient had a fall in intravascular kininogen of 60% (from 5*2 to 2 1 mol equivalents of bradykinin/litre of plasma), the maximum occurring between the 1 ½/2-and three-hour intervals; in case 2 the patient had a fall of 96% (from 2v85 to 0 18 ,imol equivalents of bradykinin/litre of plasma), the maximum occurring between the one-and three-hour intervals. by the six-hour interval. In cases 3 and 4 the patients had a less pronounced fall in kininogen of 16% and 23/o respectively, which was shorter in duration. No fall in intravascular kininogen occurred in cases 5 and 6 or in the control subject 7. The intravascular concentrations of IgG, IgM, and IgA rose slightly over the first four hours in cases 1 and 2; in cases 3 and 4 and the control subject 7 no overall changes occurred during the period of observation.
The JHR in the patients studied was associated with an early reduction in intravascular kininogen values, reflecting pronounced kinin formation. The scheme proposed by Loveday2 and others3 suggested several possible sites of kinin formation during the JHR: via immune complexes, Hageman factor, early complement components, and lysozymal enzymes. Kinins so formed would have biological properties to mediate, at least in part, the subsequent reaction. In addition they proposed that the main site of the JHR in syphilis was extravascular. This may explain why only the patients having severe reactions (and pronounced activation of kininogen) showed significant changes in kininogen in the intravascular compartment. The rapid return to normal values after 3-4 hours may not reflect cessation of activation but merely an increase in overall synthesis.
Further work is in progress to clarify the role of plasma enzyme systems in the pathogenesis of the JHR. 
